CareLit · DOI-Nachweis · Klinische Neurophysiologie
BoNT/D is effective in humans – but with higher dosing and shorter duration than BoNT/A
DOI 10.1055/s-0034-1371325
Bibliografische Angaben
Nachweis in CareLit
Autor:innenK Wohlfarth, T Fiedler, K Kollewe, F Wegner, J Weisemann, G Adeli, S Alvermann, S Böselt, C Escher, N Garde, S Gingele, SB Kaehler, R Karatschai, T Krüger, T Schmidt, S Sikorra, P Tacik, J Wollmann, R Dengler, H Bigalke, A Rummel
ZeitschriftKlinische Neurophysiologie
Ausgabe03/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Objective: The seven serotypes A-G of botulinum neurotoxins (BoNT) are extremely potent poisons but also highly effective medicines to treat hyperactive cholinergic neurons in different diseases and symptoms such as dystonias, spasticity, pain and hyperhidrosis. However, during long-term treatment patients may become non-responsive to the approved BoNT/A and B due to antibody formation. The remaining serotypes C-G m…
Zitieren
Zitierempfehlung
K Wohlfarth, T Fiedler, K Kollewe, F Wegner, J Weisemann, G Adeli, S Alvermann, S Böselt, C Escher, N Garde, S Gingele, SB Kaehler, R Karatschai, T Krüger, T Schmidt, S Sikorra, P Tacik, J Wollmann, R Dengler, H Bigalke, A Rummel (2014) BoNT/D is effective in humans – but with higher dosing and shorter duration than BoNT/A. Klinische Neurophysiologie (03). https://doi.org/10.1055/s-0034-1371325
Mit CareLit weiterarbeiten